# Nana Pogosova

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/nana-pogosova/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,051 |
| Field | Cardiac Health and Mental Health |
| h-index | 44 |
| i10-index | 96 |
| Last Known Institution | Peoples' Friendship University of Russia |
| OpenAlex ID | https://openalex.org/A5042971997 |
| ORCID iD | https://orcid.org/0000-0002-4165-804X |
| Works | 273 |

## Researcher papers

- [Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial](https://scholariq.org/papers/dulaglutide-and-cardiovascular-outcomes-in-type-2-diabetes-rewind-a-double-blind/)
- [Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-stable-cardiovascular-disease/)
- [Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study](https://scholariq.org/papers/global-and-regional-effects-of-potentially-modifiable-risk-factors-associated/)
- [EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries](https://scholariq.org/papers/euroaspire-iv-a-european-society-of-cardiology-survey-on-the-lifestyle-risk/)
- [Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry](https://scholariq.org/papers/lifestyle-and-impact-on-cardiovascular-risk-factor-control-in-coronary-patients/)
- [Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-patients-with-stable-peripheral-or/)
- [Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial](https://scholariq.org/papers/dulaglutide-and-renal-outcomes-in-type-2-diabetes-an-exploratory-analysis-of-the/)
- [Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin](https://scholariq.org/papers/safety-of-proton-pump-inhibitors-based-on-a-large-multi-year-randomized-trial-of/)
- [Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries](https://scholariq.org/papers/management-of-dyslipidaemia-in-patients-with-coronary-heart-disease-results-from/)
- [Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial](https://scholariq.org/papers/effect-of-dulaglutide-on-cognitive-impairment-in-type-2-diabetes-an-exploratory/)
- [Design and baseline characteristics of participants in the <scp>R</scp> esearching cardiovascular <scp>E</scp> vents with a <scp>W</scp> eekly <scp>IN</scp> cretin in <scp>D</scp> iabetes ( <scp>REWIND</scp> ) trial on the cardiovascular effects of dulaglutide](https://scholariq.org/papers/design-and-baseline-characteristics-of-participants-in-the-scp-r-scp-esearching/)
- [The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial](https://scholariq.org/papers/the-effect-of-dulaglutide-on-stroke-an-exploratory-analysis-of-the-rewind-trial/)

## Researcher topics

- [Cardiac Health and Mental Health](https://scholariq.org/topics/cardiac-health-and-mental-health/)
- [Healthcare Systems and Public Health](https://scholariq.org/topics/healthcare-systems-and-public-health/)
- [Cardiovascular Health and Risk Factors](https://scholariq.org/topics/cardiovascular-health-and-risk-factors/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

## Researcher university

- [Peoples' Friendship University of Russia](https://scholariq.org/institutions/peoples-friendship-university-of-russia/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.